|

Iron oxide nanoparticles Clinical Trials

1 actively recruiting trial

Also known as: Contrast agent, contrast agent

Pipeline

Phase 2: 1

Top Sponsors

  • NanoEcho AB1

Indications

  • Rectal Cancer Patients1
  • Healthy Volunteers1
  • Cancer1

Other1 trial

To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.